Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
NASH is a more severe form of non-alcoholic fatty liver disease. Learn more about this type of hepatitis on #NASHday 2021.
The small single-site study will need to be replicated in a larger group of adolescents.
Questions remain about whether people with HIV are more at risk for severe COVID-19, as evidence to date is mixed.
New guidelines recommend focusing on healthy foods but don’t restrict added sugars or alcohol as much as some experts had hoped.
This may reflect loss of the weight-suppressing effect of the older version of the drug.
Developing treatments for fatty liver disease has proved challenging, and there are currently no approved medications.
Overweight and obesity are linked to a host of health problems.
Twelve states have an adult obesity prevalence of 35% or more.
Age, underlying medical conditions, race/ethnicity and economic status all play a role in determining the risk for severe illness.
“Will we have a COVID vaccine next year tailored to the obese? No way."
The effect is greater for women, and it could have a detrimental effect on pregnancy outcomes at the population level.
This finding held true regardless of individuals’ initial weight, unless they had obesity, in a recent large study.
Having an undetectable viral load did not change the risk, which nevertheless was not as severe as the risk tied to diabetes.
Newer drug classes are tied to a higher risk of weight gain, which is more likely to occur among Black women in particular.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.